Statins do not reduce risk of osteoporotic fractures, a prespecified secondary analysis of the JUPITER trial determined. The study included 17,802 men and women with no history of atherosclerosis. The mean age was 66. During the study, 221 incident fractures occurred in the participants on rosuvastatin and 210 occurred in the placebo group. Via MedPage Today.
Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.
Did you find this article helpful?